Atlas Trials

A Study of SGN-CD228A in Advanced Solid Tumors

Clinical trial NCT04042480 · TERMINATED

Trial details

NCT number
NCT04042480
Sponsor
Seagen Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast NeoplasmsNon-small Cell Lung CancerColorectal CancerPancreatic Ductal Adenocarcinoma
Start date
2019-09-03
Primary completion
2023-03-09
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.